Table 2 Clinical characteristics of sample at inclusion (N = 45)
From: Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study
Characteristics | Â |
|---|---|
Gender, N (%) | |
 Male | 31 (68.9%) |
Age (years) | 67,58 ± 14,02 |
History of chronic kidney disease, N (%) | |
 Hypertensive nephropathy | 21 (46.7%) |
 Glomerular nephropathy | 7 (15.6%) |
 Uropathy | 5 (11.1%) |
 Diabetes | 4 (8.9%) |
  Others | 8 (17.8%) |
Antecedents, N (%) | |
 Transplantation | 11 (24.4%) |
 Diabetes | 14 (31.1%) |
 Malignant disease | 11 (24.4%) |
 Infection | 11 (24.4%) |
 Hemorrhage | 12 (26.7%) |
 Heart disease | 29 (64.4%) |
  Ischemic heart disease | 20 (44.4%) |
  Heart failure | 6 (13.3%) |
Previous time of dialysis (months) | 53,97 ± 86,26 |
Type of dialysis, n (%) | |
 Hemodialysis | 32 (71%) |
 Hemodiafiltration | 13 (29%) |
Vascular access, N (%) | |
 Arteriovenous fistula | 37 (82.2%) |
 Arteriovenous graft | 3 (6.7%) |
 Venous catheter | 5 (11.1%) |
Treatment, N (%) | |
 Anticoagulants | 7 (15.6%) |
 Antiplatelet agents | 32 (71.1%) |